Douglas Pharmaceuticals is a New Zealand success story – a rapidly expanding pharmaceutical company with a reputation for high manufacturing standards, quality products and outstanding client service.
They work hard to be the best and that effort has been recognised through the assortment of awards they have earned. In recent times they have won the 2016 Overall Supreme Winner in the AMCHAM (The American Chamber of Commerce in NZ) awards, the AMCHAM Best Large International Export award, the TIN (Technology Investment Network) EY ‘Top 10 to Watch’ – 2016, 2017 and 2018 plus we made the 2018 finals of the prestigious New Zealand International Business Awards (Best Large Business category) run by New Zealand Trade and Enterprise.
Douglas was founded in 1967 by West Auckland chemist Sir Graeme Douglas who dispensed prescription medicines. In 1980 he turned his hand to manufacturing and by the 1990s he was successfully researching and developing his own products for the domestic and international markets.
Today Douglas employs over 700 people and exports to 40 countries around the world. Douglas has sites in Fiji and Pennsylvania and is New Zealand’s largest family owned healthcare company.
Cranclense is one of the top products that have been created by Douglas Pharmaceuticals that have proudly used to support natural bladder, vaginal and urinary tract function for those needing ongoing support in those areas.